ConductScience.org, home

Gene · 8828

NRP2: neuropilin 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. NRP2: neuropilin 2. Genes, record 8828. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8828

On this page

Gene

Symbol
NRP2
HGNC
Name
neuropilin 2
HGNC
NCBI Gene ID
8828
NCBI Gene
HGNC ID
HGNC:8005
HGNC
Ensembl
ENSG00000118257
NCBI Gene
Aliases
NP2, NPN2, PRO2714, VEGF165R2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O60462Neuropilin-293116Ensembl, GeneID, HGNC

Source UniProt

Patents60

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-197773O60462Espacenet
EP 4641201 A22025-10-297851O60462Espacenet
JP 2025147176 A2025-10-069546O60462Espacenet
JP 2025529142 A2025-09-042908O60462Espacenet
JP 2025529142 A2025-09-047180O60462Espacenet
US 12397037 B22025-08-264O60462Espacenet
US 12371689 B22025-07-292908O60462Espacenet
US 12371689 B22025-07-297180O60462Espacenet
JP 2025517969 A2025-06-127851O60462Espacenet
JP 2025517970 A2025-06-127773O60462Espacenet

1 to 10 of 60

See all 60 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,960

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleNRP2 papersNewest fiscal year
P30CA016672Cancer Center Support Grant112025
P30CA030199Cancer Center Support Grant (CCSG)72025
P30CA008748Cancer Center Support Grant62025
T32CA009599Training of Academic Surgical Oncologists62025
P30CA016087Cancer Center Support Grant42025
P30CA036727Buffett Cancer Center Support Grant42025
P30CA046934University of Colorado Cancer Center Support Grant42025
P30CA138313Medical University of South Carolina - Cancer Center Support Grant42025
R01AG034962Vanderbilt Memory & Aging Project42025
R01NS097750Contribution of Innate Immune Receptors to Neurological Dysfunction After Traumatic Brain Injury: Mechanisms and Therapeutic Implications42025

1 to 10 of 1,960Source NIH's project files

See all 1,960 nih grants

Papers3,174

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Therapy-educated fibroblast states link treatment pressure to residual disease and acquired resistance in gastric cancer.Front Immunol202642812889PubTator, text miningPubMed
Exploring Genetic Clues in Kikuchi-Fujimoto Disease: A Three-Generation Study.Pharmgenomics Pers Med202642724811PubTator, text miningPubMed
Reversible Symmetry Switching, Giant Birefringence, and UV Second-Harmonic Generation in Hybrid Niobium Oxyfluorides.Angew Chem Int Ed Engl202642690036PubTator, text miningPubMed
Targeting Semaphorin-plexin Signaling in Glioblastoma: Implications for Tumor Invasion, Angiogenesis, and Treatment Resistance.Curr Neurovasc Res202642634324PubTator, text miningPubMed
Sensory neurons shape γδ T cell effector programs to control psoriasiform inflammation.J Invest Dermatol202642551506PubTator, text miningPubMed
Sensory neurons shape γδ T cell effector programs to control Psoriasiform Inflammation.bioRxiv202642465452PubTator, text miningPubMed
Single-cell mapping of extrachromosomal circular DNA architecture and evolution in cutaneous squamous cell carcinoma.Cancer Lett202642457020PubTator, text miningPubMed
[Retracted] miR-331-3p suppresses cell invasion and migration in colorectal carcinoma by directly targeting NRP2.Oncol Lett202642433654PubTator, text miningPubMed
New Therapies for Sarcoidosis: Molecular and Pathophysiological Basis.Int J Mol Sci202642353055PubTator, text miningPubMed
Integrative spatiotemporal transcriptomics identifies a liver metastasis-related initial cell population associated with the SEMA3A-NRP1 axis in pancreatic ductal adenocarcinoma.J Transl Med202642304476PubTator, text miningPubMed

1 to 10 of 3,174

See all 3,174 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/8828

GET https://conductscience.org/api/genes/v1/8828/patents?page=2